[시장보고서]희소 세포 분리 시장 : 규모, 점유율과 동향 분석, 제품별, 세포 유형별, 기술별, 지역별, 부문 예측(2025-2033년)

희소 세포 분리 시장 : 규모, 점유율과 동향 분석, 제품별, 세포 유형별, 기술별, 지역별, 부문 예측(2025-2033년)

Rare Cell Isolation Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, Instrument), By Cell Type (Circulating Tumor Cells, Stem Cells, Rare Immune Cells, Fetal Cells), By Technology, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1869762

리서치사 : Grand View Research

발행일 : 2025년 10월

페이지 정보 : 영문 120 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,845,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,332,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,305,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

희소 세포 분리 시장 요약

세계의 희소 세포 분리 시장 규모는 2024년에 20억 2,000만 달러로 평가되었고, 2033년까지 50억 9,000만 달러에 이를 것으로 예측됩니다.

2025년부터 2033년에 걸쳐 CAGR 10.85%로 성장할 전망입니다. 희소 세포 분리 시장은 생명 공학의 진보와 정밀의료에 대한 수요 증가를 배경으로 현저한 성장을 이루고 있습니다.

순환종양세포(CTCs), 줄기세포, 태아세포 등을 포함한 희소세포는 질병의 조기 발견, 치료 경과의 모니터링, 맞춤형 치료에 있어 매우 중요한 역할을 하고 있습니다.

지역별 시장 점유율 분석, 2024년 및 2033년
지역 시장 대시보드
시장 규모, 예측 동향 분석, 2021-2033년:
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제8장 경쟁 구도

기업/경쟁의 분류
전략 매핑
기업시장 포지셔닝 분석, 2024년
기업 프로파일
- Miltenyi Biotec
- Thermo Fisher Scientific, Inc.
- Danaher
- QIAGEN NV
- Bio-techne
- STEMCELL Technologies
- CELLENION
- RareCyte
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.

SHW

영문 목차

영문목차

Rare Cell Isolation Market Summary

The global rare cell isolation market size was valued at USD 2.02 billion in 2024 and is projected to reach USD 5.09 billion by 2033, growing at a CAGR of 10.85% from 2025 to 2033. The rare cell isolation market has been experiencing significant growth, driven by advancements in biotechnology and the increasing need for precision medicine.

Rare cells, which include circulating tumor cells (CTCs), stem cells, and fetal cells, play crucial roles in early disease detection, treatment monitoring, and personalized therapy.

Global Rare Cell Isolation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global rare cell isolation market report based on product, cell type, technology, and region:

Products Outlook (Revenue, USD Million, 2021 - 2033)
Reagent & Kits
Instrument
Cell Type Outlook (Revenue, USD Million, 2021 - 2033)
Circulating Tumor Cells
Stem Cells
Fetal Cells
Rare Immune Cells
Circulating Endothelial Cells
Other Rare Cell Types
Technology Outlook (Revenue, USD Million, 2021 - 2033)
Magnetic Bead Separation
Fluorescence-Activated Cell Sorting
Microfluidics-based techniques
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Products Segment
- 1.2.2. Cell Type Segment
- 1.2.3. Technology Segment
1.3. Information analysis
- 1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
- 1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

Chapter 3. Rare cell isolation market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Rising prevalence of chronic and rare diseases
  - 3.2.1.2. Technological advancement and innovation in cell isolation
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Strict regulations and compliances for cell separation
3.3. Rare Cell Isolation Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis

Chapter 4. Rare Cell Isolation Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Rare Cell Isolation Market Products Movement Analysis
4.3. Global Rare Cell Isolation Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Reagent & Kits
- 4.4.1. Reagent & kits market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Instrument
- 4.5.1. Instrument market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Rare Cell Isolation Market: Cell Type Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Rare Cell Isolation Market Application Movement Analysis
5.3. Global Rare Cell Isolation Market Size & Trend Analysis, by cell type, 2021 to 2033 (USD Million)
5.4. Circulating Tumor Cells
- 5.4.1. Circulating tumor cells market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Stem Cells
- 5.5.1. Stem cells market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Fetal Cells
- 5.6.1. Fetal cells market estimates and forecasts 2021 to 2033 (USD Million)
5.7. Rare Immune Cells
- 5.7.1. Rare immune cells market estimates and forecasts 2021 to 2033 (USD Million)
5.8. Circulating Endothelial Cells
- 5.8.1. Circulating endothelial cells market estimates and forecasts 2021 to 2033 (USD Million)
5.9. Other Rare Cell Types
- 5.9.1. Other rare cell types market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Rare cell isolation market: Technology Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Rare Cell Isolation Market Technology Movement Analysis
6.3. Global Rare Cell Isolation Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
6.4. Microfluidics-Based Techniques
- 6.4.1. Microfluidics-based techniques market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Fluorescence-Activated Cell Sorting
- 6.5.1. Fluorescence-activated cell sorting market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Rare cell isolation market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2024 & 2033
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
- 7.4.1. U.S.
  - 7.4.1.1. Key country dynamics
  - 7.4.1.2. Competitive scenario
  - 7.4.1.3. Regulatory framework
  - 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.2. Canada
  - 7.4.2.1. Key country dynamics
  - 7.4.2.2. Competitive scenario
  - 7.4.2.3. Regulatory framework
  - 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.3. Mexico
  - 7.4.3.1. Key country dynamics
  - 7.4.3.2. Competitive scenario
  - 7.4.3.3. Regulatory framework
  - 7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Europe
- 7.5.1. UK
  - 7.5.1.1. Key country dynamics
  - 7.5.1.2. Competitive scenario
  - 7.5.1.3. Regulatory framework
  - 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.2. Germany
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Competitive scenario
  - 7.5.2.3. Regulatory framework
  - 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.3. France
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Competitive scenario
  - 7.5.3.3. Regulatory framework
  - 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.4. Italy
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Competitive scenario
  - 7.5.4.3. Regulatory framework
  - 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.5. Spain
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Competitive scenario
  - 7.5.5.3. Regulatory framework
  - 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.6. Denmark
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Competitive scenario
  - 7.5.6.3. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.7. Sweden
  - 7.5.7.1. Key country dynamics
  - 7.5.7.2. Competitive scenario
  - 7.5.7.3. Regulatory framework
  - 7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.8. Norway
  - 7.5.8.1. Key country dynamics
  - 7.5.8.2. Competitive scenario
  - 7.5.8.3. Regulatory framework
  - 7.5.8.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Asia Pacific
- 7.6.1. Japan
  - 7.6.1.1. Key country dynamics
  - 7.6.1.2. Competitive scenario
  - 7.6.1.3. Regulatory framework
  - 7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.2. China
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Competitive scenario
  - 7.6.2.3. Regulatory framework
  - 7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.3. India
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Competitive scenario
  - 7.6.3.3. Regulatory framework
  - 7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.4. Australia
  - 7.6.4.1. Key country dynamics
  - 7.6.4.2. Competitive scenario
  - 7.6.4.3. Regulatory framework
  - 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.5. South Korea
  - 7.6.5.1. Key country dynamics
  - 7.6.5.2. Competitive scenario
  - 7.6.5.3. Regulatory framework
  - 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.6. Thailand
  - 7.6.6.1. Key country dynamics
  - 7.6.6.2. Competitive scenario
  - 7.6.6.3. Regulatory framework
  - 7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Latin America
- 7.7.1. Brazil
  - 7.7.1.1. Key country dynamics
  - 7.7.1.2. Competitive scenario
  - 7.7.1.3. Regulatory framework
  - 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 7.7.2. Argentina
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Competitive scenario
  - 7.7.2.3. Regulatory framework
  - 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.8. MEA
- 7.8.1. South Africa
  - 7.8.1.1. Key country dynamics
  - 7.8.1.2. Competitive scenario
  - 7.8.1.3. Regulatory framework
  - 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 7.8.2. Saudi Arabia
  - 7.8.2.1. Key country dynamics
  - 7.8.2.2. Competitive scenario
  - 7.8.2.3. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 7.8.3. UAE
  - 7.8.3.1. Key country dynamics
  - 7.8.3.2. Competitive scenario
  - 7.8.3.3. Regulatory framework
  - 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 7.8.4. Kuwait
  - 7.8.4.1. Key country dynamics
  - 7.8.4.2. Competitive scenario
  - 7.8.4.3. Regulatory framework
  - 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
- 8.4.1. Miltenyi Biotec
  - 8.4.1.1. Company overview
  - 8.4.1.2. Financial performance
  - 8.4.1.3. Product benchmarking
  - 8.4.1.4. Strategic initiatives
- 8.4.2. Thermo Fisher Scientific, Inc.
  - 8.4.2.1. Company overview
  - 8.4.2.2. Financial performance
  - 8.4.2.3. Product benchmarking
  - 8.4.2.4. Strategic initiatives
- 8.4.3. Danaher
  - 8.4.3.1. Company overview
  - 8.4.3.2. Financial performance
  - 8.4.3.3. Product benchmarking
  - 8.4.3.4. Strategic initiatives
- 8.4.4. QIAGEN N.V.
  - 8.4.4.1. Company overview
  - 8.4.4.2. Financial performance
  - 8.4.4.3. Product benchmarking
  - 8.4.4.4. Strategic initiatives
- 8.4.5. Bio-techne
  - 8.4.5.1. Company overview
  - 8.4.5.2. Financial performance
  - 8.4.5.3. Product benchmarking
  - 8.4.5.4. Strategic initiatives
- 8.4.6. STEMCELL Technologies
  - 8.4.6.1. Company overview
  - 8.4.6.2. Financial performance
  - 8.4.6.3. Product benchmarking
  - 8.4.6.4. Strategic initiatives
- 8.4.7. CELLENION
  - 8.4.7.1. Company overview
  - 8.4.7.2. Financial performance
  - 8.4.7.3. Product benchmarking
  - 8.4.7.4. Strategic initiatives
- 8.4.8. RareCyte
  - 8.4.8.1. Company overview
  - 8.4.8.2. Financial performance
  - 8.4.8.3. Product benchmarking
  - 8.4.8.4. Strategic initiatives
- 8.4.9. Illumina, Inc.
  - 8.4.9.1. Company overview
  - 8.4.9.2. Financial performance
  - 8.4.9.3. Product benchmarking
  - 8.4.9.4. Strategic initiatives
- 8.4.10. Bio-Rad Laboratories, Inc.
  - 8.4.10.1. Company overview
  - 8.4.10.2. Financial performance
  - 8.4.10.3. Product benchmarking
  - 8.4.10.4. Strategic initiatives

한글목차

희소 세포 분리 시장 요약

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 희소 세포 분리 시장의 변수, 동향, 범위

제4장 희소 세포 분리 시장 : 제품의 추정·동향 분석

제5장 희소 세포 분리 시장 : 세포 유형의 추정·동향 분석

제6장 희소 세포 분리 시장 : 기술의 추정·동향 분석

제7장 희소 세포 분리 시장 : 지역의 추정·동향 분석